These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 4577518)
41. Differences in the effect of phenobarbital treatment on the in vitro metabolism of aflatoxin and aniline by duck and rat livers. Patterson DS; Roberts BA Biochem Pharmacol; 1971 Dec; 20(12):3377-83. PubMed ID: 5132884 [No Abstract] [Full Text] [Related]
42. Aflatoxin metabolism in duck-liver homogenates: the relative importance of reversible cyclopentenone reduction and hemiacetal formation. Patterson DS; Roberts BA Food Cosmet Toxicol; 1972 Aug; 10(4):501-12. PubMed ID: 4404294 [No Abstract] [Full Text] [Related]
43. Hepatic metabolism and bioactivation of mycotoxins and plant toxins. Swick RA J Anim Sci; 1984 Apr; 58(4):1017-28. PubMed ID: 6373704 [TBL] [Abstract][Full Text] [Related]
44. Metabolism of drugs during rat liver regeneration. Henderson PT; Kersten KJ Biochem Pharmacol; 1970 Jul; 19(7):2343-51. PubMed ID: 5520377 [No Abstract] [Full Text] [Related]
45. Effect of cycloheximide on the mixed-function oxidase system of cat liver. Williams JF; Karler R Mol Pharmacol; 1971 May; 7(3):269-79. PubMed ID: 4398360 [No Abstract] [Full Text] [Related]
46. Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation. Ramsdell HS; Eaton DL Cancer Res; 1990 Feb; 50(3):615-20. PubMed ID: 2105159 [TBL] [Abstract][Full Text] [Related]
47. Long-term effects of neonatal phenobarbital exposure on aflatoxin b1 disposition in adult rats. Faris RA; Campbell TC Cancer Res; 1983 Jun; 43(6):2576-83. PubMed ID: 6406048 [No Abstract] [Full Text] [Related]
48. In vitro cytochrome P450 monooxygenase and prostaglandin H-synthase mediated aflatoxin B1 biotransformation in guinea pig tissues: effects of beta-naphthoflavone treatment. Liu L; Nakatsu K; Massey TE Arch Toxicol; 1993; 67(6):379-85. PubMed ID: 8215906 [TBL] [Abstract][Full Text] [Related]
49. Modulation of microsome-mediated aflatoxin B1 binding to exogenous and endogenous DNA by cytosolic glutathione S-transferases in rat and hamster livers. Lotlikar PD; Jhee EC; Insetta SM; Clearfield MS Carcinogenesis; 1984 Feb; 5(2):269-76. PubMed ID: 6421504 [TBL] [Abstract][Full Text] [Related]
50. Effect of ethanol on the in vivo covalent binding and in vitro metabolism of aflatoxin B1 in rats. Toskulkao C; Glinsukon T Toxicol Lett; 1986 Feb; 30(2):151-7. PubMed ID: 2422790 [TBL] [Abstract][Full Text] [Related]
51. Metabolism and activation of aflatoxin B1 by reconstituted cytochrome P-450 system of rat liver. Yoshizawa H; Uchimaru R; Kamataki T; Kato R; Ueno Y Cancer Res; 1982 Mar; 42(3):1120-4. PubMed ID: 6800645 [TBL] [Abstract][Full Text] [Related]
52. Interaction of aflatoxin B 1 metabolite with rat liver RNA. Gurtoo HL; Dave C Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):635-45. PubMed ID: 4144818 [No Abstract] [Full Text] [Related]
53. Gossypol: subcellular localization and stimulation of rat liver microsomal oxidases. Abou-Donia MB; Dieckert JW Toxicol Appl Pharmacol; 1971 Mar; 18(3):507-16. PubMed ID: 4998823 [No Abstract] [Full Text] [Related]
54. The metabolism of aflatoxin B1 by human liver. Moss EJ; Neal GE Biochem Pharmacol; 1985 Sep; 34(17):3193-7. PubMed ID: 3929787 [No Abstract] [Full Text] [Related]
55. Inhibition of rat-liver RNA polymerase in vitro by aflatoxin B1 in the presence of microsomal fraction. Akinrimisi EO; Benecke BJ; Seifart KH Eur J Biochem; 1974 Mar; 42(2):333-9. PubMed ID: 4829436 [No Abstract] [Full Text] [Related]
56. Inhibition of in vitro protein synthesis by aflatoxin B1 derivatives. Sarasin A; Moulè Y FEBS Lett; 1973 Jun; 32(2):347-50. PubMed ID: 4733784 [No Abstract] [Full Text] [Related]